Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company dedicated to creating new standards of care for patients.
We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune disease. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class.
Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.
We push conventional boundaries from candidate selection to differentiated therapeutic, applying rigorous go/no go criteria at each stage of development to fast-track only the most promising molecules to the clinic and, ultimately, commercialization.
With deep scientific expertise, our teams exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients.
Summary:
The Head of Toxicology will be responsible for providing the overall toxicology strategy as well as program specific toxicology packages to support regulatory submissions for Cullinan’s immunology and oncology portfolio. The Head of Toxicology will work in a team-based setting to plan and execute nonclinical studies, provide nonclinical safety assessments, draft regulatory documents and contribute to achieving program goals. The successful candidate will have experience managing outsourced nonclinical GLP and non-GLP safety studies, including design, monitoring, execution and reporting of studies. As the nonclinical safety assessment lead for multiple programs, they will have responsibility for authoring regulatory documents and responses to inquiries from health authorities addressing global nonclinical development issues in support of IND/CTA/NDA filings. The successful candidate will have substantial experience in autoimmune disease and/or oncology drug development with the ability to contribute effectively to cross-functional drug development teams.
Cullinan Therapeutics is proud to be an Equal Opportunity Employer. We are committed to creating an inclusive and diverse environment for all employees and applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.